Bristol-Myers Squibb Company

Location

New Jersey

Founded

1887-04-10

Risk Signals

10468 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about Bristol-Myers Squibb Company

Live alerts from global media, monitored by Business Radar

Britannia Life Sciences Inc. Reports Fourth Quarter and Fiscal Year Financial Results for 2024, by @newsfile

2024-09-03 (ceo.ca)

Britannia Life Sciences Inc. Reports Fourth Quarter and Fiscal Year Financial Results for 2024, by @newsfile

Toronto, Ontario--(Newsfile Corp. - September 2, 2024) - Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") is pleased report its financial results for the year ended March 31, 2024. The Company 's audited annual financial statements and related management 's discussion and

Read more
Bristol-Myers Gets First Nod for $11 Million HIV Drug Settlement

2022-06-06 (bloomberglaw.com)

Bristol-Myers Gets First Nod for $11 Million HIV Drug Settlement

Bristol-Myers Squibb Co. inched closer to exiting antitrust litigation over Gilead Sciences Inc. 's blockbuster HIV drugs, when a federal judge in San Francisco granted preliminary approval to its$ 11 million class action settlement with wholesalers

Read more
Bristol-Myers Gets First Nod for $11 Million HIV Drug Settlement

2022-06-06 (bloomberglaw.com)

Bristol-Myers Gets First Nod for $11 Million HIV Drug Settlement

Bristol-Myers Squibb Co. inched closer to exiting antitrust litigation over Gilead Sciences Inc. 's blockbuster HIV drugs, when a federal judge in San Francisco granted preliminary approval to its$ 11 million class action settlement with wholesalers

Read more
Bristol-Myers Gets First Nod for $11 Million HIV Drug Settlement

2022-06-06 (bloomberglaw.com)

Bristol-Myers Gets First Nod for $11 Million HIV Drug Settlement

Bristol-Myers Squibb Co. inched closer to exiting antitrust litigation over Gilead Sciences Inc. 's blockbuster HIV drugs, when a federal judge in San Francisco granted preliminary approval to its$ 11 million class action settlement with wholesalers

Read more
Exelixis Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

2019-02-12 (businesswire.com)

Exelixis Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the fourth quarter and full year 2018 and provided an update on progress toward ful

Read more
SEC Charges Bristol-Myers Squibb With FCPA Violations

2015-10-05 (sec.gov)

SEC Charges Bristol-Myers Squibb With FCPA Violations

05-10-2015 · The SEC’s order finds that Bristol-Myers Squibb violated the FCPA’s internal controls and recordkeeping provisions. Without admitting or denying the findings, Bristol-Myers Squibb consented to the order and agreed to return$ 11.4 million

Read more
SEC Charges Bristol-Myers Squibb With FCPA Violations

2015-10-05 (sec.gov)

SEC Charges Bristol-Myers Squibb With FCPA Violations

05-10-2015 · The SEC’s order finds that Bristol-Myers Squibb violated the FCPA’s internal controls and recordkeeping provisions. Without admitting or denying the findings, Bristol-Myers Squibb consented to the order and agreed to return$ 11.4 million

Read more

Never miss a headline about Bristol-Myers Squibb Company

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages